Table 3 Covariate balance between the patients with adjuvant chemotherapy and adjuvant ICIs.
From: Trends in the use and efficacy of adjuvant immunotherapy in muscle-invasive urothelial carcinoma
Covariate balance | Mean or % (adjuvant chemo.) | Mean or % (adjuvant ICIs) | SMD (Unweighted) | Weighted mean or % (adjuvant chemo.) | Weighted mean or % (adjuvant ICIs) | SMD (IPTW-weights) | SMD (IPTW-ATT) |
|---|---|---|---|---|---|---|---|
Age | 67.6 | 70.6 | 0.33 | 68.10 | 65.5 | 0.06 | 0.08 |
sex | 75.0% | 69.8% | 0.11 | 74.4% | 89.9% | 0.12 | 0.03 |
ECOG PS | 0.08 | 0.08 | 0.02 | 0.08 | 0.02 | 0.06 | 0.02 |
UTUC | 54.0% | 34.9% | 0.39 | 50.5% | 22.0% | 0.33 | < 0.01 |
NAC | 25.7% | 96.8% | 2.12 | 38.8% | 34.5% | 1.30 | < 0.01 |
pT | 3.02 | 2.79 | 0.34 | 2.97 | 2.90 | 0.34 | 0.04 |
Variant histology | 13% | 17% | 0.11 | 14% | 5% | 0.04 | 0.09 |
